Ion Complexation of 2-(2′-Hydroxyphenyl)benzazoles
J. Phys. Chem. A, Vol. 106, No. 21, 2002 5213
(18), 198 (38). EI-HRMS m/e calculated for C15H11NO5
dust particles or fibers. UV-vis absorption spectra were
recorded at 25 °C using a Varian Cary Bio50 UV-vis
spectrometer with constant-temperature accessory. Steady-state
emission and excitation spectra were recorded with a PTI
fluorimeter and FELIX software. Throughout the titration the
sample solution was stirred with a magnetic stirring device. For
all titrations the path length was 1 cm with a cell volume of
3.0 mL. All fluorescence spectra have been corrected for the
spectral response of the detection system (emission correction
file provided by instrument manufacturer) and for the spectral
irradiance of the excitation channel (via calibrated photodiode).
Quantum yields were determined using quinine sulfate dihydrate
in 1.0 N H2SO4 (Φf ) 0.54 ( 0.05) as fluorescence standard.46
Electrode Calibration in Aqueous Solution. Measurements
were performed with a Mettler Inlab combination glass electrode
(Model No. 423). For the determination of the pK values in
aqueous solution, the electrode was calibrated for -log[H3O+]
by titration of a standardized HCl solution (Aldrich, 0.1 N
volumetric standard) with KOH (Aldrich, 0.1 N volumetric
standard) at 25 °C and 0.1 M ionic strength (KCl). The end
point, E°, and slope were determined using Gran’s method47 as
implemented in the software GLEE.48 The calibration procedure
was repeated three times prior to each pK value determination.
The electrode potential was measured with the Corning pH/Ion
Analyzer 355 and the emf measurements were reproducible with
(0.1 mV accuracy. For the determination of the apparent
stability constants, the electrode was calibrated using commercial
pH reference solutions.
Determination of pK Values. All protonation constants
reported in this study were determined from absorption meas-
urements. The UV-vis absorption spectra of the ligands were
monitored for a series of solution in which -log[H3O+] was
varied between 5 and 11. The emf of each solution was directly
measured in the UV quartz cell (electrode diameter 3 mm) and
converted to -log[H3O+] using E° and slope as obtained from
the electrode calibration procedure described above. The raw
spectral and emf data were processed via nonlinear least-squares
fit analysis using the SPECFIT software package.49
Complex Stability Constants. All measured cation stability
constants K, reported herein, were measured at pH 7.2 (PIPES
10 mM, 0.1 M KNO3 ionic strength) and are therefore apparent
stability constants. To 3.0 mL of a 30 µM solution of the
corresponding ligand in PIPES buffer (10 mM, pH 7.20, 0.1 M
KNO3) were added 5 µL aliquots of Zn(OTf)2 stock solution
(concentration 5 mM, 50 mM or 0.5 M). Upon each addition
the solution was stirred for 15 min to reach equilibrium and
the UV-vis spectrum was subsequently monitored. The re-
corded UV-vis traces were analyzed by a nonlinear least-
squares fit algorithm using an equilibrium model with 1:1
complex stoichiometry (SPECFIT software).49
285.06372, found 285.05910.
(e) [4-(1H-Benzimidazol-2-yl)-3-hydroxy-phenoxy)]-acetic
acid ethyl ester (5a). A solution of aldehyde 1 (200 mg, 0.89
mmol) and o-phenylenediamine (96 mg, 0.89 mmol) in EtOH
(10 mL) was heated under reflux for 2 h. After addition of 1,4-
benzoquinone (192 mg, 1.78 mmol) the mixture was further
refluxed for 0.5 h. The reaction mixture was cooled to room
temperature, and quenched by dropwise addition of saturated
aq. NaHCO3 (20 mL). The mixture was extracted with EtOAc
(2 × 20 mL) and the combined organic layers were washed
with H2O (2 × 10 mL), dried (MgSO4), and concentrated in
vacuo. The residue was further purified on silica gel (FC,
hexanes-EtOAc, 4:1 f 2:1, yielding 245 mg (0.78 mmol, 87%)
of imidazole 5a as colorless solid. mp 194-196 °C; Rf 0.36
1
(2:1 hexane:EtOAc); H NMR (CDCl3, 300 MHz) δ 1.23 (t, J
) 7.1 Hz, 3H), 4.20 (q, J ) 7.1 Hz, 2H), 4.85 (s, 2H), 6.57 (d,
J ) 2.5 Hz, 1H), 6.65 (dd, J ) 8.8, 2.5 Hz, 1H), 7.22-7.28
(m, 2H), 7.62 (s, broad, 2H), 7.95 (d, J ) 8.8 Hz, 1H), 13.0 (s,
broad, 1H), 13.4 (b, broad, 1H); MS (70 eV) 312 (M+, 100),
197 (30). EI-HRMS m/e calculated for C17H16N2O4 312.11101,
found 312.11186.
(f) [4-(1H-Benzimidazol-2-yl)-3-hydroxy-phenoxy)]-acetic
acid (5b). Ester 5a (200 mg, 0.64 mmol) was hydrolyzed
following the procedure as described for ester 4a yielding 135
mg (0.47 mmol, 74%) of acid 5b as tan solid. mp > 300 °C;
1H NMR (DMSO-d6, 300 MHz) δ 4.75 (s, 2H), 6.55 (d, J )
2.2 Hz, 1H), 6.64 (dd, J ) 8.8, 2.2 Hz, 1H), 7.27 (dd, J ) 6.0,
3.0 Hz, 2H), 7.63 (dd, J ) 6.0, 3.1 Hz, 2H), 7.99 (d, J ) 8.8
Hz, 1H), 13.18 (s, broad, 3H); MS (70 eV) 284 (M+, 100), 197
(61), 36 (23). EI-HRMS m/e calculated for C15H12N2O4
284.07971, found 284.07969.
(g) (4-Benzothiazol-2-yl-3-hydroxy-phenoxy)-acetic acid
ethyl ester (6a). To a hot solution of FeCl3‚6 H2O (462 mg,
1.71 mmol) in EtOH (5 mL) a solution of imine 3 (142 mg,
0.43 mmol) in EtOH (2 mL) was added, and the resulting
mixture was heated under reflux for 0.5 h. The dark mixture
was cooled to room temperature, diluted with H2O (3 mL) and
extracted with EtOAc (2 × 10 mL). The combined organic
extracts were dried (MgSO4) and concentrated in vacuo afford-
ing a brown residue, which was further purified on silica gel
(FC, hexanes-EtOAc, 5:1 f 3:1, providing 76 mg (0.23 mmol,
54%) of benzothiazole 6a as pale greenish solid mp 137-139
1
°C; Rf 0.38 (3:1 hexane:EtOAc); H NMR (CDCl3, 300 MHz)
δ 1.32 (t, J ) 7.1 Hz, 3H), 4.30 (q, J ) 7.1 Hz, 2H), 4.67 (s,
2H), 6.55-6.62 (m, 2H), 7.38 (t, J ) 7.1 Hz, 1H), 7.49 (t, J )
8.2 Hz, 1H), 7.60 (d, J ) 8.8 Hz, 1H), 7.87 (d, J ) 8.8 Hz,
1H), 7.94 (d, J ) 8.2 Hz, 1H), 12.71 (s, broad, 1H); MS (70
eV) 329 (M+, 100), 256 (20), 226 (38), 214 (43), 198 (31).
EI-HRMS m/e calculated for C17H15NO4S 329.07218, found
329.07211.
Results and Discussion
(h) (4-Benzothiazol-2-yl-3-hydroxy-phenoxy)-acetic acid
(6b). Ester 6a (44 mg, 0.13 mmol) was hydrolyzed following
the procedure as described for ester 4a affording 31 mg (0.103
mmol, 77%) of acid 6b as pale tan solid: mp 226-228 °C; 1H
NMR (DMSO-d6, 300 MHz) δ 4.75 (s, 2H), 6.57 (d, J ) 2.8
Hz, 1H), 6.62 (dd, J ) 11.1, 2.6 Hz, 1H), 7.40 (td, J ) 8.7 Hz,
1.6 Hz, 1H), 7.52 (td, J ) 8.7 Hz, 1.6 Hz, 1H), 7.98-8.10 (m,
3H), 11.81 (s, broad, 1H), 13.12 (s, broad, 1H); MS (70 eV)
301 (M+, 100), 214 (45), 186 (18). EI-HRMS m/e calculated
for C15H11NO4S 301.04088, found 301.04140.
Synthesis. The preparation of all three benzazole derivatives
4-6 is based on the salicylic aldehyde precursor 1 which was
synthesized according to a published procedure (Scheme 2).45
The benzoxazole derivative 4a was obtained by condensation
of 1 with 2-aminophenol to give the Schiff base 2. Initial
attempts to cyclize and oxidize 2 with Fe(III) chloride resulted
in hydrolysis of the imino group, and aldehyde 1 was the only
observed product. In contrast, treatment with barium man-
ganate gave the desired oxazole 4a, but only with low yield.
The low yield is presumably due to decomposition, since no
other products could be isolated. Benzimidazole 5a was
synthesized via condensation of 1 with o-phenylenediamine
followed by oxidation of the dihydroimidazole intermediate with
Steady-State Absorption and Fluorescence Spectroscopy.
All sample stock solutions and buffer solutions were filtered
through 0.2-µm nylon membrane filters to remove interfering